Publication:
The Correlation Between Systemic Inflammatory Response And Survival in Patients with Metachronous and Synchronous Liver Metastatic Colorectal Cancer

dc.contributor.authorEsra ERKEK TURAN
dc.contributor.authorElif Alp POSTEKİ
dc.contributor.authorGokhan POSTEKİ
dc.contributor.authorAhmet ERKEK
dc.contributor.authorMehmet ALİUSTAOGLU
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionBAHÇEŞEHİR ÜNİVERSİTESİ
dc.contributor.institutionYEDİTEPE ÜNİVERSİTESİ
dc.date.accessioned2025-09-20T19:59:29Z
dc.date.issued2020
dc.date.submitted24.10.2020
dc.description.abstractObjectives: Recent data suggest that a low lymphocyte count in a colorectal tumor is associated with poor prognosis.The NLR has been shown to be an effective prognostic factor for survival in colorectal and ovarian cancer. It has beensuggested that the preoperative NLR may be a simple method to identify patients with a poor prognosis of colorectalcancer. The aim of this study was to evaluate the effect of the NLR on survival in patients with colorectal cancer whounderwent liver metastasectomy.Methods: The study included 76 patients who were admitted to the Medical Oncology Outpatient Clinic of Kartal Dr.Lutfi Kırdar Training and Research Hospital, who underwent liver metastasectomy and were followed up for colorectalcancer and whose clinical data and pre-metastasectomy laboratory values could be retrieved. The SPSS 17.0 softwarepackage was used in the analysis of the study. The mean, standard deviation, minimum-maximum, median, rate andfrequency values were used for the descriptive statistics of the data. The distribution of the variables was assessed bythe Kolmogorov Smirnov test. The independent samples t-test and Mann-Whitney U test were used for the analysis ofquantitative data. The chi-square test was used for analysis of qualitative data. The Cox regression and Kaplan-Meiersurvival analysis were used for survival analyses. Spearman’s correlation analysis was used for correlation analyses.Results: Age had a significant effect on survival time in the univariate model (p<0.05). Sex, colonic localization, lymphnode involvement, histological grade, metastatic status, surgical margin, diameter of metastases, number of metastases, leukocytes, neutrophils, lymphocytes, NLR, CRP, albumin and CEA parameters had no significant effect on survivalin the univariate model (p>0.05).Conclusion: In our study, when a survival analysis was carried out on all variables, the only variable affecting survivalwas age. The mean age of the metasynchronous group was 56.2±10.6 years, and the mean age of the synchronousgroup was 61.3±11.1 years. Despite the numerical difference, there was no statistical significance (p=0.055). Althoughthe mean age of the synchronous group was numerically higher, the survival was longer. This may be due to the shortfollow-up time and the small sample size
dc.identifier.doi10.14744/ejmi.2019.18112
dc.identifier.endpage23
dc.identifier.issn2602-3164
dc.identifier.issue1
dc.identifier.startpage17
dc.identifier.urihttps://hdl.handle.net/20.500.14719/5172
dc.identifier.volume4
dc.language.isoen
dc.relation.journalEurasian Journal of Medical Investigation
dc.subjectOnkoloji
dc.subjectİmmünoloji
dc.subjectCerrahi
dc.titleThe Correlation Between Systemic Inflammatory Response And Survival in Patients with Metachronous and Synchronous Liver Metastatic Colorectal Cancer
dc.typeResearch Article
dcterms.references1. W Chaua, K A Charles, V E Baracos, S J Clar, et al. Neutrophil/lympocyte ratio predicts chemoterapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011,104:1288–95.,2. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. International Archives of Medicine 2012,5:2.,3. Tsujimura A, Kawamura N, Ichimura T, et al. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas. Int J Oncol 2002,20:361–5.,4. Blake-Mortimer JS, Sephton SE, Carlson RW, et al. Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer. Breast J 2004,10:195–9.,5. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005,91:181–4.,6. Lee WS, Yun SH, Chun HK, et al. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis 2007,22:699–704.,7. Van Cutsem E, Nordlinger B, Adam R,et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006,42:2212–21.,8. Yoo PS, Lopez-Soler RI, Longo WE, Cha CH.Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer 2006,6:202–7.,9. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000,231:487–99.,10. Nordlinger B, Quilichini MA, Parc R, Hannoun L, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987,205:256–63.,11. Steven R. Alberts, William L., et al.Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study. JCO 2005,23:36:924.,12. Fong Y, Fortner J, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999,230:309–18.,13. Muratore A, Zorzi D, et al. Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy? Annals of Surgical Oncology 2007,14:2:766–770.,14. Hayashi M, Inoue Y, Komeda K, et al. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg 2010,10:27.,15. Foster JH. Treatment of metastatic disease of the liver: a skeptic's view. Semin Liver Dis 1984,4:170–9.,16. Manfredi S, Lepage C, et al. Epidemiology and Management of Liver Metastases From Colorectal Cancer. Ann Surg 2006,244:254–259.,17. Mekenkamp LJM, Koopman M, Teerenstra S. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. British Journal of Cancer 2010,103:159–164.,18. Stangl R, Altendorf-Hofmann A, et al. Factors influcing the natural history of colorectal liver metastases. Lancet 1994,343:1405–10.,19. Choti MA, Sitzmann JV, et al. Trends in long term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002,235:759–66.,20. Pawlik TM, Scoggins CR, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005,124:715–122. EJMI 23,21. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004,240:644–57.,22. Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003,90:567–74.,23. Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin 1999,49:231–55.,24. Tsai MS, Su YH, Ho MC, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol 2007,14:786–94.,25. Zhang S, Gao F, Luo J, Yang J, et al. Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis. Colorectal Dis 2010,12:754–61.,26. Chua W, Charles KA, Baracos VE, Clarke SJ, et al. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011,104:1288–95.,27. Lee YY, Choi CH, Kim HJ, et al. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res 2012,32:1555–61.,28. Noh H, Eomm M, Han A.Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer 2013,16:55–9.,29. He W, Yin C, Guo G, et al. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol 2013,30:439.,30. Nishikawa H, Arimoto A, et al. Pre-treatment C-reactive protein as a prognostic factor for recurrence after surgical resection of hepatocellular carcinoma. Anticancer Res 2013,33:1181–8
dspace.entity.typePublication
local.indexed.atTRDizin

Files